Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast to 2031: By Type (Hemodialysis, Peritoneal Dialysis), Product (Device, Consumables, Service), End Use (Home-Based, Hospital-Based), and Region

Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast to 2031: By Type (Hemodialysis, Peritoneal Dialysis), Product (Device, Consumables, Service), End Use (Home-Based, Hospital-Based), and Region

The global hemodialysis and peritoneal dialysis market were valued at USD 81.8 billion in 2021 and it is anticipated to grow further up to USD 148.4 billion by 2031, at a CAGR of 6.1% during the forecast period.

Dialysis is a procedure used to remove waste products from the blood, such as urea and creatinine, which are caused by the kidneys' improper functioning and are typically necessary for those with chronic renal failure. Hemodialysis and peritoneal dialysis are the two types of this treatment used to treat renal problems. Hemodialysis involves pumping blood out of blood vessels, purifying it with a dialyzer, and then reintroducing it to the body via vascular access. The basic idea behind the process is the same as peritoneal dialysis, except the peritoneum, the inner lining of the stomach, is utilized as a filter to clean the blood.

Market Trends and Drivers

The demand for hemodialysis and peritoneal dialysis is being driven by a number of factors, including the increasing prevalence of acute kidney injury (AKI), a lack of organ donors, the risks associated with transplants, technological advancements, and initiatives by the major players to introduce cutting-edge products and services. Additionally, the COVID-19 pandemic outbreak has increased the need for dialysis significantly around the world. As a result, the industry has seen increased financial incentives and regulatory support from several government agencies. Throughout the projected period, these elements are anticipated to support the market's expansion.

Furthermore, it is anticipated that the need for home care dialysis services would continue to rise. Acute and chronic kidney disease patients are treated at home or in outpatient settings. As a result, there is a greater need for renal home treatments. In addition, the NCBI reports that, as of 2017, 10.8% of Americans used home dialysis, a 30 percent rise over the previous ten years. The Advancing Kidney Health Initiative made the suggestion in 2019 to treat more patients with renal failure at home using hemodialysis or peritoneal dialysis. In addition, CMS suggested a target of having 80% of dialysis patients get their care in a home environment.

Market Restraints and Challenges

Increased dialysis-related side effects including infections, hypotension, fluid overload, and access point hemorrhage are projected to restrain market expansion in the years to come. Similar issues with reimbursement policies in developing countries limit market expansion. This is explained by the fact that compensation for dialysis varies significantly in terms of quantity and duration between different nations and does not always account for actual treatment expenses, which discourages patients and doctors from thinking about how to use the policy.

Global Hemodialysis and Peritoneal Dialysis Market Segmental Overview

The report analyses the global hemodialysis and peritoneal dialysis market based on type, product, end user, and region.

Global Hemodialysis and Peritoneal Dialysis Market by Type

Based on the type, it is segmented into hemodialysis and peritoneal dialysis. In 2021, the hemodialysis segment dominated the market with the highest revenue and CAGR during the projection period. The hemodialysis market is also further divided into nighttime hemodialysis and typical, brief daily hemodialysis. Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis are two further subgroups of peritoneal dialysis (APD). Significant market drivers include an increase in ESRD patients, a rise in the elderly population with kidney illnesses, and an increase in the frequency of diabetes and hypertension. The report World Population Ageing 2020 stated that 727 million individuals worldwide were 65 or older. By 2050, it is anticipated that the population will have more than doubled to around 1.5 billion people. The segment growth is anticipated to be greatly accelerated by the aging population and the increased risk of CKD.

Global Hemodialysis and Peritoneal Dialysis Market by Product

Based on the product, it is segmented into devices, consumables, and services. The service segment is likely to dominate the market during the forecast period. This can be linked to an increase in the prevalence of ESRD and an increase in the number of dialysis service providers. Additionally, a number of significant dialysis service providers are attempting to diversify their service portfolios by opening and acquiring new dialysis facilities around the globe, which is anticipated to stimulate segment expansion. Numerous manufacturers' activities and technological developments are anticipated to further accelerate market expansion. For instance, DaVita added a safe telehealth solution called DaVita Care Connect to its home dialysis business in February 2021. It was one of many connective technologies included in its offering of services with the goal of enhancing care and results for patients who decide to take care of themselves at home.

Global Hemodialysis and Peritoneal Dialysis Market by End User

Based on the end user, it is segmented into home-based and hospital-based. In 2021, the hospital-based segment dominated the market with the highest market share and CAGR during the forecast period. The substantial supply of highly skilled and seasoned healthcare staff at hospitals will likely allow the industry to maintain its lead over the coming years. In healthcare environments like hospitals and dialysis clinics, the presence of a qualified and experienced renal care team guarantees effective treatment and improved dialysis outcomes. The segment is expected to be driven by a number of factors, including the increasing emphasis on developing independent dialysis centers by companies and the rising uptake of in-center dialysis by patients. Additionally, businesses are concentrating on creating hemodialysis machines that can perform a range of interventions. The end-user experience is likely to be impacted by this.

Geographical Analysis of the Global Hemodialysis and Peritoneal Dialysis Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market with the highest market share with the largest revenue in 2021. The region's market is expanding as a result of the existence of key players, large government investments in the creation of cutting-edge medical devices, and a favorable reimbursement environment. Dialysis is becoming more popular as a result of the increase in kidney failures and chronic kidney diseases (CKD). High disposable income, government initiatives, and rising healthcare spending are a few major reasons boosting the market.

Over the projected period, the Asia Pacific area is anticipated to have the greatest CAGR. Rising renal failure cases, an aging population, and increased product development are anticipated to fuel market expansion over the course of the projected period. In addition, the IDF estimates that 88 million adults in South East Asia currently have diabetes, with 153 million likely to have the disease by 2045. In addition, increased government initiatives, CKD awareness programs, technologically advanced products, the availability of newly built, state-of-the-art healthcare facilities in the area, and rising healthcare spending are a few other factors influencing market growth.

Major Players in the Global Hemodialysis and Peritoneal Dialysis Market

COVID-19 Impact

The global market for dialysis care had been severely disrupted by the COVID-19 pandemic. Because of the pandemic's high hospitalization rates, the demand for dialysis equipment and supplies has suddenly increased. For instance, according to CDC estimates from 2021, an estimated 37 million Americans, or 1 in 7 U.S. adults, were affected by CKD. The higher prevalence of coexisting diseases like CKD, diabetes, and hypertension was primarily to blame for this. The epidemic also caused significant supply-chain disruptions, which made it difficult for producers to keep up with demand. The aging population's increasing medical needs, the increased demand for novel products and treatments, and developments in medical technology are all predicted to contribute to the market's continued expansion after COVID-19. Additionally, increasing public and commercial sector initiatives to promote home HD/PD may open up more lucrative market opportunities after COVID-19.

Recent Developments

  • May 2021, Mar Cor (Cantel Medical Corporation) announced the launch of its innovative EON Portable hemodialysis water system.
  • October 2020, Fresenius Medical Care AG & Co. KGaA announced the launch of a PVC-free peritoneal dialysis solution bag designed for dialysis therapy performed at home.
  • August 2020, Baxter International Inc. received FDA approval for De Novo application for Theranova dialyzers designed to deliver expanded hemodialysis (HDx) therapy.
  • January 2019, AWAK Technologies received FDA breakthrough designation for the company’s Peritoneal Dialysis Mix device, a wearable dialysis device used for patients suffering from kidney diseases.
Frequently Asked QuestionsQ1. How big is the Hemodialysis and Peritoneal Dialysis market?Ans. The global Hemodialysis and Peritoneal Dialysis market size was USD 81.8 million in 2021 and is anticipated to reach USD 148.4 million in 2031, growing at a rate of 6.1% from 2022 to 2031.Q2. What is the Hemodialysis and Peritoneal Dialysis market growth rate?Ans. The growth rate of the Hemodialysis and Peritoneal Dialysis market is 6.1%.Q3. Which region holds a major market share for the Hemodialysis and Peritoneal Dialysis market?Ans. North America holds a major market share of the Hemodialysis and Peritoneal Dialysis market in 2021.Q4. Which segment accounted for the largest Hemodialysis and Peritoneal Dialysis market share?Ans. By end user, home-based segment accounted for the largest Hemodialysis and Peritoneal Dialysis market share.Q5. Who are the key players in the Hemodialysis and Peritoneal Dialysis market?Q6. What are the factors driving the Hemodialysis and Peritoneal Dialysis market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.Q7. What are the key growth strategies of Hemodialysis and Peritoneal Dialysis market players?Ans. The key growth strategies of Hemodialysis and Peritoneal Dialysis market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Hemodialysis and Peritoneal Dialysis market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Hemodialysis and Peritoneal Dialysis market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.


Chapter 1. Market Introduction
1.1. Objectives Of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of The Market
Chapter 3. Hemodialysis and Peritoneal Dialysis Market Outlook
3.1. Hemodialysis and Peritoneal Dialysis Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat Of New Entrants
3.3.2. Threat Of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. Pestle Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers And/or Retailers
3.6. Impact Of the Russia and Ukraine War on The Global Hemodialysis and Peritoneal Dialysis Market
Chapter 4. The Economic Impact of Covid-19
4.1. Overall Impact of Covid-19
4.2. Impact Of Covid on The Global Hemodialysis and Peritoneal Dialysis Market
4.3. Economic Impact Analysis
Chapter 5. Hemodialysis and Peritoneal Dialysis Market by Type
5.1. Market Overview
5.2. Hemodialysis
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
5.3. Peritoneal Dialysis
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
Chapter 6. Hemodialysis and Peritoneal Dialysis Market by Product
6.1. Market Overview
6.2. Device
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.3. Consumables
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
6.4. Services
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
Chapter 7. Hemodialysis and Peritoneal Dialysis Market by End Use
7.1. Market Overview
7.2. Home Based
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
7.3. Hospital Based
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
Chapter 8. Global Hemodialysis and Peritoneal Dialysis Market, By Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.3. North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.2.4. North America Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.5. The U.S.
8.2.5.1. The U.S. Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.5.2. The U.S. Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.2.6. Canada
8.2.6.1. Canada Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.6.2. Canada Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.2.7. Mexico
8.2.7.1. Mexico Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.7.2. Mexico Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use Product, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.3. Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.3.4. Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.5. Germany
8.3.5.1. Germany Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.5.2. Germany Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.3.6. France
8.3.6.1. France Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.6.2. France Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.3.7. U.K.
8.3.7.1. U.K. Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.7.2. U.K. Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.3.8. Spain
8.3.8.1. Spain Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.8.2. Spain Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.3.9. Italy
8.3.9.1. Italy Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.9.2. Italy Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.3.10. Russia
8.3.10.1. Russia Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.10.2. Russia Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.3.11. Rest Of Europe
8.3.11.1. Rest Of Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.11.2. Rest Of Europe Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.4. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.4.5. China
8.4.5.1. China Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.5.2. China Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.4.6. India
8.4.6.1. India Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.6.2. India Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.4.7. Japan
8.4.7.1. Japan Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.7.2. Japan Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.4.8. South Korea
8.4.8.1. South Korea Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.8.2. South Korea Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.4.9. Rest Of APAC
8.4.9.1. Rest Of APAC Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.9.2. Rest Of APAC Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.5. Rest Of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest Of the World Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.3. Rest Of the World Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.5.4. Rest Of the World Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.5. Latin America
8.5.5.1. Latin America Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.5.2. Latin America Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.5.6. Middle East
8.5.6.1. Middle East Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.6.2. Middle East Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
8.5.7. Africa
8.5.7.1. Africa Hemodialysis and Peritoneal Dialysis Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.7.2. Africa Hemodialysis and Peritoneal Dialysis Market Size and Forecast by End Use, 2021-2031, ($Million)
Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New End Use Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, And Collaborations
9.3.5. Mergers And Acquisitions
Chapter 10. Company Profiles
10.1. FRESENIUS SE AND CO. KGAA
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. ASAHI KASEI CORPORATION
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. B. BRAUN MELSUNGEN AG
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. BAXTER INTERNATIONAL INC.
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. COOK GROUP
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. ANGIODYNAMICS INC.
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. MEDTRONIC PLC.
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. NIKKISO CO. LTD.
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. NIPRO CORPORATION
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The List of Company Is Subject to Change During the Final Compilation of The Report

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings